# Tesamorelin / Ipamorelin

> Markdown version of this page, for agents. To send a shopper here, link https://www.besthealthiq.com/__fluid_affiliate_username__/posts/tesamorelin-ipamorelin (not this .md URL, and keep its path as given).

- Published: 2026-08-28
- Author: Best Health IQ
- Summary: A synergistic GHRH + GHRP combination for enhanced GH pulsatility and visceral fat reduction.
- Shopper link: https://www.besthealthiq.com/__fluid_affiliate_username__/posts/tesamorelin-ipamorelin

## Tesamorelin / Ipamorelin Combination A synergistic GHRH + GHRP combination for enhanced GH pulsatility and visceral fat reduction. \*\*Category:\*\* Blends & Combos · \*\*Evidence:\*\* Moderate Evidence · \*\*Status:\*\* Research Only ### Description This combination pairs Tesamorelin (GHRH analog) with Ipamorelin (GHRP) for synergistic GH release. Tesamorelin provides the GHRH stimulus while Ipamorelin amplifies the GH pulse through GHS-R1a, resulting in greater GH secretion than either alone. ### Key Characteristics - \*\*Molecular Weight:\*\* Not specified - \*\*Half-Life:\*\* Varies - \*\*Administration Routes:\*\* Subcutaneous injection - \*\*Typical Dose:\*\* 0.75 mg to 2.25 mg - \*\*Frequency:\*\* Daily (bedtime preferred) - \*\*Cycle Length:\*\* 8–16 weeks ### Investigated Benefits - Synergistic GH release - Improved body composition - Better sleep quality - Visceral fat reduction - Enhanced recovery \\\* Benefits based on preclinical/animal research unless otherwise noted. ### Mechanism of Action Tesamorelin activates GHRH receptors to stimulate GH synthesis. Ipamorelin activates GHS-R1a to amplify the GH pulse. The dual mechanism produces 3–5x greater GH release than either peptide alone. ### Dosing & Protocol - \*\*Typical Dose:\*\* 0.75 mg to 2.25 mg - \*\*Frequency:\*\* Daily (bedtime preferred) - \*\*Cycle Length:\*\* 8–16 weeks - \*\*Administration:\*\* Subcutaneous injection \*\*Protocol Notes:\*\* Administer on empty stomach. Bedtime dosing maximizes natural GH pulse. Monitor IGF-1 levels every 3 months. ### Reconstitution Guide Per prescriber instructions. ### Storage Information Lyophilized: refrigerate. Reconstituted: refrigerate and use within 30 days. ### Quality & Sourcing Standards When sourcing Tesamorelin / Ipamorelin for research purposes, the following quality benchmarks should be verified before use. - \*\*Purity:\*\* \>98% (verified by HPLC) - \*\*Certificate of Analysis (COA):\*\* Must be provided by supplier - \*\*Endotoxin Testing:\*\* \<0.1 EU/mg (prevents bacterial contamination) - \*\*GMP Compliance:\*\* Manufactured in cGMP-certified facility - \*\*Third-Party Testing:\*\* Independent lab verification preferred ### Research Highlights 1. Tesamorelin FDA-approved for HIV-associated lipodystrophy 2. Ipamorelin demonstrated selective GH release without cortisol elevation 3. Combination produces synergistic GH pulse ### Evidence Level \*\*Moderate Evidence\*\* — Multiple animal studies and/or early human trials. Reasonable confidence in mechanism, but human data is limited. ### FDA Disclaimer The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.